Rocket Lab Q1 2026: Record Revenue But Losses Persist, Neutron Schedule Remains Key Risk

What happened

Rocket Lab reported Q1 2026 revenue of $200.3M (above guidance), with Space Systems contributing $136.7M and Launch Services $63.7M, while gross margin improved to 38.2%. Despite the top-line beat, the company posted an operating loss of $56.0M and a net loss of $45.0M, with operating cash burn of $50.3M, reinforcing its dependence on external financing. Management reiterated a Q4 2026 target for Neutron's first launch after the January tank failure, but the earnings call lacked quantified milestone updates on tank requalification or Archimedes engine testing. Meanwhile, the $445.6M in net ATM proceeds raised in Q1 2026 boosted liquidity to $1.48B, but also diluted shareholders by over 29 million shares in the quarter. The call did not provide new catalysts to de-risk the Neutron timeline or clarify when equity issuance would cease, leaving the stock's valuation precariously tied to program execution rather than current earnings.

Implication

The Q1 2026 call confirmed strong operational execution on Electron and Space Systems, but offered no new evidence that Neutron's schedule risk is declining. With the stock pricing in defense-driven growth and a successful late-2026 Neutron debut, investors should require visible progress on tank requalification and Archimedes testing before committing new capital. The attractive entry point remains near $65, while trimming above $90 is prudent given the asymmetry of downside from further Neutron delays or renewed equity issuance.

Thesis delta

The earnings call reinforces the existing WAIT thesis: record revenue and robust backlog confirm the current business is scaling, but the absence of quantified Neutron milestone progress and continued reliance on ATM financing keep the risk/reward unfavorable. No catalyst emerged to shift the rating; the stock remains a milestone-dependent bet with a wide range of outcomes.